# Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy

> **NCT06902623** · NA · RECRUITING · sponsor: **Georgetown University** · enrollment: 30 (estimated)

## Conditions studied

- Oropharyngeal Cancers
- HPV
- Tonsil Cancer
- Base of Tongue Cancer

## Interventions

- **RADIATION:** Radiation

## Key facts

- **NCT ID:** NCT06902623
- **Lead sponsor:** Georgetown University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-08-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06902623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06902623, "Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06902623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*